Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
NEW YORK, Dec. 31, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.
The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market.
The estimated value of the market was calculated based on the materials, (industry) products, and applications revenue. Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on industry, the market is classified into pharmaceutical, in-vitro diagnostics, and drug delivery devices. The pharmaceutical segment is categorized into microfluidics chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The microfluidics chips for lab analytics segment is further classified into toxicity screening, proteomic analysis, gene sequencing, and capillary electrophoresis. In-vitro diagnostics is further segmented into clinical diagnostics, Point-of-Care diagnostics, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.
Based on applications, the market is categorized into six applications, namely, drug delivery, industrial and environmental, analytical devices, pharmaceutical and life science research, Point-of-Care diagnostics, and clinical and veterinary diagnostics. The Point-of-Care diagnostics segment commands the largest share of the global applications market. It is expected to grow at a strong CAGR during the study period. The large share of this segment is attributed to the increased adoption of microfluidics in Point-of-Care diagnostics by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.).
North America dominates the market, accounting for around one-third of the share. The leading market share of the North American region is attributed to the presence of a large number of major manufacturers such as, Abbott Laboratories, Agilent Technologies, Caliper Life Sciences (PerkinElmer), and Johnson & Johnson, in this region. Additionally, the rising adoption of microfluidics technology and the increasing rate of new product launches in the North American region are the favorable factors driving the market growth.
Global Microfluidics Market Scenario
Microfluidics Market
Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 REPORT DESCRIPTION 21
1.3 MARKETS COVERED 23
1.4 STAKEHOLDERS 24
1.5 MARKET SCOPE 25
1.6 RESEARCH METHODOLOGY 26
1.6.1 MARKET SIZE ESTIMATION 27
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 28
1.6.3 KEY DATA POINTS FROM PRIMARY SOURCES 31
1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 32
1.6.5 ASSUMPTIONS 33
2 EXECUTIVE SUMMARY 34
3 PREMIUM INSIGHTS 37
3.1 GLOBAL MICROFLUIDICS MARKET, A SNAPSHOT (2013) 37
3.2 MARKET DYNAMICS 38
3.3 MICROFLUIDICS MARKET, BY INDUSTRY 39
3.4 MICROFLUIDICS MARKET, BY APPLICATIONS 40
3.5 GEOGRAPHIC ANALYSIS & MATERIALS MARKET 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 43
4.2 MARKET SEGMENTATION 44
4.3 MARKET DYNAMICS 46
4.3.1 DRIVERS 46
4.3.1.1 Rising demand for Point-of-Care (POC) testing to drive the market 46
4.3.1.2 Quick return on investments helping in cost reductions 46
4.3.1.3 Microfluidic chips miniaturization helps to reduce testing time and cost 46
4.3.2 RESTRAINTS 47
4.3.2.1 The incorporation of emerging microfluidic technology into existing workflows is challenging 47
4.3.2.2 Complex and time consuming regulatory standards to lengthen the approval process 47
4.3.3 OPPORTUNITIES 48
4.3.3.1 Growing Asian market 48
4.3.3.2 Shifting trend towards polymers adoption 48
4.3.3.3 Expanding applications of drug delivery technologies 49
4.3.4 TRENDS 49
4.3.4.1 Increasing number of patent applications 49
4.3.5 CHALLENGES FOR MANUFACTURERS 50
4.3.5.1 Geometrical issues 50
4.3.5.2 Surface chemistry issues 50
4.3.6 WINNING IMPERATIVES 51
4.3.6.1 Standardization 51
4.3.6.2 Compatibility 51
4.4 STRATEGIC BENCHMARKING 52
4.4.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT 53
4.4.1.1 Collaboration between Fluidigm Corporation and Olink Bioscience 53
4.4.1.2 Agreement between Agilent Technologies, Inc. and Caliper Life Sciences, Inc. 53
4.4.1.3 Agreement between PerkinElmer and GenMark Diagnostics, Inc. 53
4.4.1.4 Collaboration between Roche Diagnostics and Immatics Biotechnologies GmbH 54
4.4.1.5 Agreement between RainDance Technologies and Myriad Genetics, Inc. 54
5 MICROFLUIDICS MARKET, BY MATERIAL 55
5.1 INTRODUCTION 56
5.2 POLYMER-BASED MICROFLUIDICS 60
5.3 GLASS-BASED MICROFLUIDICS 62
5.4 SILICON-BASED MICROFLUIDICS 64
5.5 OTHER MATERIALS-BASED (PAPER & CERAMICS) MICROFLUIDICS 66
6 MICROFLUIDIC DEVICES MARKET, BY INDUSTRY 68
6.1 INTRODUCTION 69
6.2 PHARMACEUTICALS 73
6.2.1 MICROFLUIDIC CHIPS FOR LAB ANALYTICS 75
6.2.1.1 Toxicity screening 77
6.2.1.2 Proteomic analysis 79
6.2.1.3 Gene sequencing 80
6.2.1.4 Capillary electrophoresis 82
6.2.2 ACCURATE DISPENSING DEVICES 83
6.2.3 MICROREACTORS FOR DRUG SYNTHESIS 84
6.3 IN-VITRO DIAGNOSTICS 86
6.3.1 CLINICAL DIAGNOSTICS 87
6.3.2 POINT-OF-CARE (POC) 89
6.3.3 ENVIRONMENTAL TESTING 90
6.3.4 INDUSTRIAL TESTING 91
6.3.5 AGRO FOOD TESTING 92
6.4 DRUG DELIVERY DEVICES 94
6.4.1 INHALER NOZZLES 95
6.4.2 MICRONEEDLES 97
6.4.3 MICROPUMPS 98
7 MICROFLUIDICS DEVICES MARKET, BY APPLICATIONS 100
7.1 INTRODUCTION 101
7.2 DRUG DELIVERY 103
7.3 INDUSTRIAL & ENVIRONMENTAL 104
7.4 ANALYSIS (TOXICITY SCREENING, PROTEOMIC ANALYSIS & GENE SEQUENCING) 106
7.5 PHARMACEUTICAL & LIFE SCIENCE RESEARCH 107
7.6 POINT OF CARE DIAGNOSTICS 109
7.7 CLINICAL & VETERINARY DIAGNOSTICS 110
8 GEOGRAPHIC ANALYSIS 112
8.1 INTRODUCTION 113
8.2 NORTH AMERICA 116
8.3 EUROPE 125
8.4 ASIA 134
8.5 REST OF THE WORLD (ROW) 143
9 COMPETITIVE LANDSCAPE 150
9.1 INTRODUCTION 150
9.2 MERGERS & ACQUISITIONS 151
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 153
9.4 NEW PRODUCT LAUNCHES 154
9.5 EXPANSION 156
9.6 APPROVALS 157
10 COMPANY PROFILES 158
10.1 ABBOTT LABORATORIES, INC. 158
10.2 AGILENT TECHNOLOGIES 165
10.3 PERKINELMER, INC. 171
10.4 BARTELS MIKROTECHNIK GMBH 178
10.5 SCIENION AG 181
10.6 CEPHEID, INC. 185
10.7 FLUIDIGM CORPORATION 191
10.8 RAINDANCE TECHNOLOGIES 199
10.9 BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE 204
10.10 BIO-RAD LABORATORIES, INC. 210
10.11 BIOFLUIDIX GMBH 215
10.12 DANAHER CORPORATION 217
10.13 JOHNSON & JOHNSON 222
10.14 LIFE TECHNOLOGIES CORPORATION 228
10.15 MICROFLUIDIC CHIPSHOP GMBH 234
10.16 ROCHE DIAGNOSTICS LIMITED 236
10.17 SIEMENS HEALTHCARE 242
COMPETITIVE DEVELOPMENTS (2011-2013) 248
LIST OF TABLES
TABLE 1 GLOBAL MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 35
TABLE 2 GLOBAL MICROFLUIDIC MATERIALS MARKET: REVENUE, BY TYPE, 2011-2018 ($MILLION) 58
TABLE 3 MICROFLUIDIC MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 59
TABLE 4 POLYMER-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 61
TABLE 5 GLASS-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 63
TABLE 6 SILICON-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 65
TABLE 7 PAPER & CERAMICS-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 67
TABLE 8 MICROFLUIDICS PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 72
TABLE 9 MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 74
TABLE 10 MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 75
TABLE 11 MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 76
TABLE 12 MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 77
TABLE 13 MICROFLUIDIC CHIPS FOR TOXICITY SCREENING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 78
TABLE 14 MICROFLUIDIC CHIPS FOR PROTEOMIC ANALYSIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 80
TABLE 15 MICROFLUIDIC CHIPS FOR GENE SEQUENCING MARKET REVENUE,
BY GEOGRAPHY, 2011-2018 ($MILLION) 81
TABLE 16 MICROFLUIDIC CHIPS FOR CAPILLARY ELECTROPHORESIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 82
TABLE 17 MICROFLUIDIC ACCURATE DISPENSING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 83
TABLE 18 MICROFLUIDIC MICROREACTORS FOR DRUG SYNTHESIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 85
TABLE 19 MICROFLUIDIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 86
TABLE 20 MICROFLUIDIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 87
TABLE 21 MICROFLUIDIC CLINICAL DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 88
TABLE 22 MICROFLUIDICS POINT OF CARE MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 90
TABLE 23 MICROFLUIDIC ENVIRONMENTAL TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 91
TABLE 24 MICROFLUIDIC INDUSTRIAL TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 92
TABLE 25 MICROFLUIDIC AGRO FOOD TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 93
TABLE 26 MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 94
TABLE 27 MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 95
TABLE 28 MICROFLUIDIC INHALER NOZZLES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 96
TABLE 29 MICROFLUIDIC MICRONEEDLES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 97
TABLE 30 MICROFLUIDIC MICROPUMPS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 98
TABLE 31 GLOBAL MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 102
TABLE 32 MICROFLUIDICS DRUG DELIVERY APPLICATIONS MARKET REVENUE,
BY GEOGRAPHY, 2011-2018 ($MILLION) 103
TABLE 33 MICROFLUIDICS INDUSTRIAL & ENVIRONMENTAL APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 105
TABLE 34 MICROFLUIDICS ANALYSIS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 106
TABLE 35 MICROFLUIDICS PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 108
TABLE 36 MICROFLUIDICS POINT OF CARE DIAGNOSTICS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 110
TABLE 37 MICROFLUIDICS CLINICAL & VETERINARY DIAGNOSTICS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 111
TABLE 38 GLOBAL MICROFLUIDICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 115
TABLE 39 NORTH AMERICA: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 118
TABLE 40 NORTH AMERICA: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 119
TABLE 41 NORTH AMERICA: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 120
TABLE 42 NORTH AMERICA: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 121
TABLE 43 NORTH AMERICA: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 122
TABLE 44 NORTH AMERICA: MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 123
TABLE 45 NORTH AMERICA: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 124
TABLE 46 EUROPE: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 127
TABLE 47 EUROPE: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 128
TABLE 48 EUROPE: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 129
TABLE 49 EUROPE: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 130
TABLE 50 EUROPE: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 131
TABLE 51 EUROPE: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 132
TABLE 52 EUROPE: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 133
TABLE 53 ASIA: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 136
TABLE 54 ASIA: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 137
TABLE 55 ASIA: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 138
TABLE 56 ASIA: MICROFLUIDICS CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 139
TABLE 57 ASIA: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 140
TABLE 58 ASIA: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 141
TABLE 59 ASIA: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 142
TABLE 60 ROW: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 144
TABLE 61 ROW: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 145
TABLE 62 ROW: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 145
TABLE 63 ROW: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 146
TABLE 64 ROW: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 147
TABLE 65 ROW: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 148
TABLE 66 ROW: MICROFLUIDIC APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 149
TABLE 67 MERGERS & ACQUISITIONS, 2011-2013 152
TABLE 68 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES, 2011-2013 153
TABLE 69 NEW PRODUCT LAUNCHES, 2011-2013 155
TABLE 70 EXPANSION, 2011-2012 156
TABLE 71 APPROVALS, 2013 157
TABLE 72 LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 229
LIST OF FIGURES
FIGURE 1 MARKET CRACKDOWN & DATA TRIANGULATION METHODOLOGY FOR MICROFLUIDICS MARKET 29
FIGURE 2 MARKET FORECASTING MODEL 30
FIGURE 3 RESEARCH OUTPUT: 360O VALIDATION 31
FIGURE 4 GLOBAL MICROFLUIDICS MARKET, BY PRODUCTS, 2013-2018 ($MILLION) 36
FIGURE 5 GLOBAL MICROFLUIDICS MARKET, 2013 37
FIGURE 6 MICROFLUIDICS MARKET DYNAMICS 38
FIGURE 7 MICROFLUIDICS MARKET, BY INDUSTRY, 2013-2018 39
FIGURE 8 MICROFLUIDICS MARKET, BY APPLICATIONS, 2013 VS 2018 40
FIGURE 9 MICROFLUIDICS MARKET: GEOGRAPHIC ANALYSIS, 2013 ($MILLION) 41
FIGURE 10 MICROFLUIDICS MARKET SEGMENTATION 45
FIGURE 11 TECHNOLOGY ADOPTION & PRODUCT ENHANCEMENT 52
FIGURE 12 MICROFLUIDICS MARKET: BY MATERIALS, 2011-2018 (MARKET SIZE & GROWTH RATES) 57
FIGURE 13 GLOBAL POLYMERS MARKET COMPARISON, 2013 VS 2018 60
FIGURE 14 MICROFLUIDICS MARKET, BY PRODUCTS, 2013-2018 70
FIGURE 15 MICROFLUIDICS PRODUCTS MARKET REVENUE, BY INDUSTRY – A FOCUS ON IVD (2013) 71
FIGURE 16 GLOBAL MICROFLUIDICS MARKET, BY APPLICATIONS, 2013-2018 101
FIGURE 17 OPPORTUNITY MATRIX: MICROFLUIDICS MARKET, BY GEOGRAPHY, 2013-2018 114
FIGURE 18 KEY GROWTH STRATEGIES IN MICROFLUIDICS MARKET, 2011-2013 150
FIGURE 19 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 159
FIGURE 20 ABBOTT LABORATORIES, INC.: GEOGRAPHIC REVENUE MIX, 2012 160
FIGURE 21 ABBOTT LABORATORIES, INC.: BUSINESS REVENUE MIX, 2012 160
FIGURE 22 ABBOTT LABORATORIES, INC.: MARKET STRATEGY, 2011-2013 162
FIGURE 23 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 166
FIGURE 24 AGILENT TECHNOLOGIES: BUSINESS REVENUE MIX, 2012 167
FIGURE 25 AGILENT TECHNOLOGIES: MARKET STRATEGY, 2010-2012 169
FIGURE 26 PERKINELMER, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 172
FIGURE 27 PERKINELMER, INC.: GEOGRAPHIC REVENUE MIX, 2012 172
FIGURE 28 PERKINELMER, INC.: BUSINESS REVENUE MIX, 2012 173
FIGURE 29 PERKINELMER, INC.: MARKET STRATEGY, 2011-2012 176
FIGURE 30 SCIENION AG: MARKET STRATEGY, 2012-2013 183
FIGURE 31 CEPHEID, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($MILLION) 186
FIGURE 32 CEPHEID, INC.: GEOGRAPHIC REVENUE MIX, 2012 186
FIGURE 33 CEPHEID, INC.: BUSINESS REVENUE MIX, 2012 187
FIGURE 34 CEPHEID, INC.: MARKET STRATEGY, 2011-2013 188
FIGURE 35 FLUIDIGM CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($MILLION) 192
FIGURE 36 FLUIDIGM CORPORATION: GEOGRAPHIC REVENUE MIX, 2012 193
FIGURE 37 FLUIDIGM CORPORATION: BUSINESS REVENUE MIX, 2012 193
FIGURE 38 FLUIDIGM CORPORATION: MARKET STRATEGY, 2011-2013 195
FIGURE 39 RAINDANCE TECHNOLOGIES: MARKET STRATEGY, 2011-2013 201
FIGURE 40 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 205
FIGURE 41 BD DIAGNOSTICS: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 206
FIGURE 42 BECTON, DICKINSON AND COMPANY: MARKET STRATEGY, 2011-2013 207
FIGURE 43 BIO-RAD LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 211
FIGURE 44 BIO-RAD LABORATORIES, INC.: MARKET SRATEGY, 2011-2013 213
FIGURE 45 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 218
FIGURE 46 DANAHER CORPORATION: MARKET STRATEGY, 2011-2013 220
FIGURE 47 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLLION) 223
FIGURE 48 JOHNSON & JOHNSON: DIAGNOSTICS FRANCHISE REVENUE, 2010-2012 ($MILLION) 224
FIGURE 49 JOHNSON & JOHNSON: MARKET STRATEGY, 2011-2013 226
FIGURE 50 LIFE TECHNOLOGIES CORPORATION: MARKET STRATEGY, 2012-2013 232
FIGURE 51 ROCHE HOLDINGS: DIAGNOSTICS REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 237
FIGURE 52 ROCHE HOLDINGS: DIAGNOSTICS REVENUE, BY GEOGRAPHY, 2010-2012 ($MILLION) 238
FIGURE 53 ROCHE HOLDINGS: MARKET STRATEGY, 2011-2013 240
FIGURE 54 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 243
FIGURE 55 SIEMENS HEALTHCARE: MARKET STRATEGY, 2011-2013 245
To order this report: Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
http://www.reportlinker.com/p01934867/Microfluidics-Market-By-Materials-Polymers-Silicon-Glass-Pharmaceuticals-Microreactors-Toxicity-Screening-Lab-on-Chip-Proteomic--Genomic-Analysis-Drug-Delivery-Devices-Microneedles-Micropumps-IVD-POC---Global-Trends--Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article